3 MAY

NEW ZEALAND GAZETTE

1037

The Balmoral Seventh Day Adventist School Board of Trustees Election Invalidation Notice

Pursuant to clauses 9 (3) and (3A) of the Sixth Schedule to the Education Act 1989, and acting with authority delegated by the Minister of Education, I hereby declare invalid the election for the staff representative for the Board of Trustees of Balmoral Seventh Day Adventist School held on 30 March 2001, and require a new election to be held on 11 June 2001, and declare that the trustee holding office on 30 March 2001 remains in office until the close of the day before the day when the new trustee takes office.

This notice takes effect the day after its notification in the New Zealand Gazette.

Dated at Wellington this 27th day of April 2001.

KATHY PHILLIPS, Senior Manager, National Operations.

go3090

The Rai Valley Area School Board of Trustees Election Validation Notice

Pursuant to clause 9 (1) of the Sixth Schedule to the Education Act 1989, and acting with authority delegated by the Minister of Education, I hereby validate the election for parent representatives for the Board of Trustees of Rai Valley Area School held on 30 March 2001, on the grounds that although an irregularity occurred in the election process it did not materially affect the result of the election.

This notice takes effect the day after its notification in the New Zealand Gazette.

Dated at Wellington this 30th day of April 2001.

KATHY PHILLIPS, Senior Manager, National Operations.

go3042

Health

Medicines Act 1981

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Cancidas

Active Ingredient(s): Caspofungin acetate 57.8mg equivalent to 50mg caspofungin anhydrous free base

Dosage Form: Vial + transfer set, powder for infusion

New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited

Manufacturer(s): Merck & Co Inc, West Point, Pennsylvania, United States of America

Note: This consent is valid for 2 years from the date of publication of this notice.

Product: Cancidas

Active Ingredient(s): Caspofungin acetate 60.6mg equivalent to 50mg caspofungin anhydrous free base

Dosage Form: Powder for injection

New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited

Manufacturer(s): Merck & Co Inc, West Point, Pennsylvania, United States of America

Note: This consent is valid for 2 years from the date of publication of this notice.

Product: Cancidas

Active Ingredient(s): Caspofungin acetate 83.9mg equivalent to 70mg caspofungin anhydrous free base

Dosage Form: Powder for infusion

New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited

Manufacturer(s): Merck & Co Inc, West Point, Pennsylvania, United States of America

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 26th day of April 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go3073

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Aerius

Active Ingredient(s): Desloratadine 5mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Schering-Plough Pty Limited

Manufacturer(s): Schering-Plough SpA, Comazzo, Italy